Clinical Trial Update: Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on genistein concentrated polysaccharide (GCP) for prostate cancer on active surveillance; completed Phase 2/Phase 3 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Genistein Concentrated Polysaccharide (GCP) (genistein concentrated polysaccharide)

Snippet

Sponsor: University of California, Davis | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED